Association of TP53 codon 72 polymorphism with cervical cancer risk in Chinese women

Cancer Genetics and Cytogenetics

Volumn 197, Issue 2, 2010, Pages 174-178

  Jiang, Pei ^a,b   Liu, Jianxin ^a   Zeng, Xiaoxi ^b   Li, Wen ^a   Tang, Jianxin ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b HUNAN UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; DNA; PROLINE; PROTEIN P53;

ADULT; ALLELE; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CANCER GRADING; CANCER RISK; CARCINOGENESIS; CHINA; CHINESE; CODON; CONTROLLED STUDY; EXON; FEMALE; GENE AMPLIFICATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PERIPHERAL LYMPHOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR VOLUME; UTERINE CERVIX CANCER;

ADULT; ARGININE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHINA; CODON; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; PROLINE; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 77249149408     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.11.011     Document Type: Article

References (34)

1. Vizcaino A.P., Moreno V., Bosch F.X., Munoz N., Barros-Dios X.M., and Borras J. International trends in incidence of cervical cancer: II. Squamous-cell carcinoma. Int J Cancer 86 (2000) 429-435
2. Burger R.A., Monk B.J., Kurosaki T., Anton-Culver H., Vasilev S.A., and Berman M.L. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer. J Natl Cancer Inst 88 (1996) 1361-1368
3. Schiffman M.H., and Brinton L.A. The epidemiology of cervical carcinogenesis. Cancer 76 (1995) 1888-1901
4. Eduardo L.F., Eliane D.F., and Ferenczy A. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. Can Med Assoc J 164 (2001) 1017-1025
5. Koushik A., Platt R.W., and Franco E.L. p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review. Cancer Epidemiol Biomarkers Prev 13 (2004) 11-22
6. Hainaut P., and Hollstein M. p53 and human cancer: the first thousand mutations. Adv Cancer Res 77 (2000) 81-137
7. Pim D., and Banks L. p53 polymorphism variants at codon72 exerts different effects on cell cycle progression. Int J Cancer 108 (2004) 196-199
8. Storey A., Thomas M., Kalita A., Harwood C., Gardiol D., and Mantovani F. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393 (1998) 229-234
9. Dumont P., Leu J.I., Della Pietra III A.C., George D.L., and Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33 (2003) 357-365
10. Yang Y.C., Chang C.L., and Chen M.L. Effect of p53 polymorphism on the susceptibility of cervical cancer. Gynecol Obstet Invest 51 (2001) 197-201
11. Ojeda J.M., Ampuero S., Rojas P., Prado R., Allende J.E., and Barton S.A. p53 codon 72 polymorphism and risk of cervical cancer. Biol Res 36 (2003) 279-283
12. Zehbe I., Voglino G., Wilander E., Genta F., and Tommasino M. Codon 72 polymorphism of p53 and its association with cervical cancer. Lancet 354 (1999) 218-219
13. Zheng X.Z., Yang A.Q., Pan X.L., Zheng L.L., Wang X.L., and Zhou Q.Y. Ethnicity determines association of p53Arg72Pro alleles with cervical cancer in China. Eur J Cancer Prev 17 (2008) 460-466
14. Li T., Lu Z.M., Guo M., Wu Q.J., Chen K.N., and Xing H.P. p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China. Cancer 95 (2002) 2571-2576
15. Nishikawa A., Fujimoto T., Akutagawa N., Iwasaki M., Takeuchi M., Fujinaga K., et al. p53 Polymorphism (codon-72) has no correlation with the development and the clinical features of cervical cancer. Int J Gynecol Cancer 10 (2000) 402-407
16. Malcolm E.K., Baber G.B., Boyd J.C., and Stoler M.H. Polymorphism at codon 72 of p53 is not associated with cervical cancer risk. Mod Pathol 13 (2000) 373-378
17. Wong Y.F., Chung T.K., Cheung T.H., Nobori T., Hampton G.M., and Wang V.W. p53 polymorphism and human papillomavirus infection in Hong Kong women with cervical cancer. Gynecol Obstet Invest 50 (2000) 60-63
18. Ngan H.Y., Liu V.W., and Liu S.S. Risk of cervical cancer is not increased in Chinese carrying homozygous arginine at codon 72 of p53. Br J Cancer 80 (1999) 1828-1829
19. Wang N.M., Tsai C.H., Yeh K.T., Chen S.J., and Chang J.G. P53 codon 72 Arg polymorphism is not a risk factor for carcinogenesis in the chinese. Int J Mol Med 4 (1999) 249-252
20. Beckman G., Birgander R., Sjalander A., Saha N., Holmberg P.A., and Kivela A. Is p53 polymorphism maintained by natural selection?. Hum Hered 44 (1994) 266-270
21. Sousa H., Santos A.M., Pinto D., and Medeiros R. Is the p53 codon 72 polymorphism a key biomarker for cervical cancer development? A meta-analysis review within European populations. Int J Mol Med 20 (2007) 731-741
22. Baccouche S., Mabrouk I., Said S., Mosbah A., Jlidi R., and Gargouri A. A more accurate detection of codon 72 polymorphism and LOH of the TP53 gene. Cancer Lett 189 (2003) 91-96
23. Mitra S., Misra C., Singh R.K., Panda C.K., and Roychoudhury S. Association of specific genotype and haplotype of p53 gene with cervical cancer in India. J Clin Pathol 58 (2005) 26-31
24. Arbel-Alon S., Menczer J., Feldman N., Glezerman M., Yeremin L., and Friedman E. Codon 72 polymorphism of p53 in Israeli Jewish cervical cancer patients and healthy women. Int J Gynecol Cancer 12 (2002) 741-744
25. Tenti P., Vesentini N., Rondo-Spaudo M., Zappatore R., Pa M., and Carnevali L. p53 Codon 72 polymorphism does not affect the risk of cervical cancer in patients from northern Italy. Cancer Epidemiol Biomarkers Prev 9 (2000) 435-438
26. Santos A.M., Sousa H., Catarino R., Pinto D., Pereira D., and Vasconcelos A. TP53 codon 72 polymorphism and risk for cervical cancer in Portugal. Cancer Genet Cytogenet 159 (2005) 143-147
27. Kim J.W., Roh J.W., Park N.H., Song Y.S., Kang S.B., and Lee H.P. Polymorphism of TP53 codon 72 and the risk of cervical cancer among Korean women. Am J Obstet Gynecol 184 (2001) 55-58
28. Makni H., Franco E.L., Kaiano J., Villa L.L., Labrecque S., and Dudley R. p53 polymorphism in codon 72 and risk of human papillomavirus-induced cervical cancer: effect of inter-laboratory variation. Int J Cancer 87 (2000) 528-533
29. Nagpal J.K., Sahni S., and Das B.R. P53 codon 72 polymorphism and susceptibility to development of human papilloma virus-associated cervical cancer in Indian women. Eur J Clin Invest 32 (2002) 943-948
30. Hou M.M., Xi M.R., Cao Z.Y., Yang K.X., and Sun Z.L. Analysis of p53 codon 72 polymorphism and its association with human papillomavirus 16 and 18 E6 in Chinese cervical lesions. Int J Gynecol Cancer 16 (2006) 2004-2008
31. Pegoraro R.J., Rom L., Lanning P.A., Moodley M., Naiker S., and Moodley J. P53 codon 72 polymorphism and human papillomavirus type in relation to cervical cancer in South African women. Int J Gynecol Cancer 12 (2002) 383-388
32. Andersson S., Rylander E., Strand A., Sallstrom J., and Wilander E. The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas. Br J Cancer 85 (2001) 1153-1156
33. Brenna S.M., Silva I.D., Zeferino L.C., Pereira J.S., Martinez E.Z., and Syrjanen K.J. Prognostic value of P53 codon 72 polymorphism in invasive cervical cancer in Brazil. Gynecol Oncol 93 (2004) 374-380
34. Janicek M.F., and Averette H.E. Cervical cancer: prevention, diagnosis, and therapeutics. CA Cancer J Clin 51 (2001) 92-114